Daraxonrasib, a pancreatic cancer drug from Revolution Medicines, is showing unprecedented success. For patients like Leanna ...
Trump directed the federal government to rush access to psychedelic treatments and reevaluate their status as controlled ...
As one CDC employee, who asked not to be named, put it on Friday, among staff “the general vibe is guarded but hopeful.” ...
When health care infrastructure is attacked and held for ransom by hackers, patients become real casualties,” writes Andrea ...
Schwartz's background as a physician with plenty of government service experience will likely be popular among lawmakers.
On Monday, Politico published a poll on vaccine attitudes titled, “More Americans doubt vaccine safety than trust it, ...
A pancreatic cancer expert on why Revolution Medicines’ study could ‘open up a new era’ of treatment
Revolution Medicines announced a stunning survival benefit for its experimental drug in a Phase 3 pancreatic cancer study ...
A few transplant patients in a small study were able to stop using immunosuppressive drugs, thanks to pre-transplant cell ...
New research challenges what we know about GLP-1s, vaccine skepticism, and more health news from Morning Rounds ...
Scientists are raising a provocative hypothesis about GLP-1 drugs for obesity: Perhaps targeting the GLP-1 hormone isn't ...
Scientists whose work led to powerful obesity drugs like Zepbound are now suggesting targeting the GLP-1 hormone is not ...
The FDA will convene an outside panel of advisers to discuss whether to allow compounding pharmacies to manufacture certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results